66 related articles for article (PubMed ID: 2600822)
1. Antagonism by tricyclic antidepressants of the muscarinic receptors located on the adrenergic nerve endings in rabbit heart atrium.
Somogyi GT; Perel JM
J Pharmacol Exp Ther; 1989 Dec; 251(3):922-8. PubMed ID: 2600822
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.
Crews FT; Smith CB
J Pharmacol Exp Ther; 1980 Oct; 215(1):143-9. PubMed ID: 6256516
[TBL] [Abstract][Full Text] [Related]
3. Biphasic effect of tricyclic antidepressants on the release of norepinephrine from the adrenergic nerves of the rabbit heart.
Somogyi GT; Perel JM
Psychopharmacology (Berl); 1991; 104(2):237-43. PubMed ID: 1876668
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029
[TBL] [Abstract][Full Text] [Related]
5. [Postsynaptic attack of tricyclic antidepressive agents in the circulatory system].
Bobkiewicz T; Chodera A; Szpunar K; Drutel B
Acta Biol Med Ger; 1975; 34?710():1675-9. PubMed ID: 1233850
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and thermodynamic considerations regarding the inhibition by tricyclic antidepressants of the uptake of tritiated norepinephrine by the adrenergic nerves in rabbit aortic strips.
Maxwell RA; Eckhardt SB; Hite G
J Pharmacol Exp Ther; 1970 Jan; 171(1):62-9. PubMed ID: 5410938
[No Abstract] [Full Text] [Related]
7. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
8. Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum.
James MK; Cubeddu LX
J Pharmacol Exp Ther; 1984 Apr; 229(1):98-104. PubMed ID: 6707949
[TBL] [Abstract][Full Text] [Related]
9. Evidence that halothane inhibits norepinephrine release from sympathetic nerve endings in dog saphenous vein by stimulation of presynaptic inhibitory muscarinic receptors.
Rorie DK; Tyce GM; Mackenzie RA
Anesth Analg; 1984 Dec; 63(12):1059-64. PubMed ID: 6507906
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic inhibition of cardiac norepinephrine and neuropeptide Y release during ischemia and reperfusion.
Haunstetter A; Haass M; Yi X; Krüger C; Kübler W
Am J Physiol; 1994 Dec; 267(6 Pt 2):R1552-8. PubMed ID: 7810765
[TBL] [Abstract][Full Text] [Related]
11. The determination of presynaptic KA values of methacholine and pilocarpine and of a presynaptic receptor reserve in the rat perfused heart.
Fuchs P; Fuder H
Br J Pharmacol; 1985 Jan; 84(1):35-46. PubMed ID: 2983804
[TBL] [Abstract][Full Text] [Related]
12. Effects of ouabain on the nerve stimulation-evoked release of norepinephrine from the isolated perfused guinea-pig heart.
Panek RL; Gaddis RR; Dixon WR
J Pharmacol Exp Ther; 1986 Jan; 236(1):212-8. PubMed ID: 3941393
[TBL] [Abstract][Full Text] [Related]
13. Tricyclic antidepressants and histamine H1 receptors.
Richelson E
Mayo Clin Proc; 1979 Oct; 54(10):669-74. PubMed ID: 39202
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular side effects of tricyclic antidepressants - a risk in the use of these drugs.
Biamino G; Fenner H; Schüren KP; Neye J; Ramdohr B; Lohmann RW
Int J Clin Pharmacol Biopharm; 1975 Apr; 11(3):253-61. PubMed ID: 1150371
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of acidosis, high potassium concentrations, and metabolic inhibition on noradrenaline release and its presynaptic muscarinic regulation.
Haunstetter A; Schulze Icking B; Backs J; Krüger C; Haass M
Pharmacol Res; 2002 Mar; 45(3):221-8. PubMed ID: 11884219
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin B2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons.
Kurz T; Tölg R; Richardt G
J Mol Cell Cardiol; 1997 Sep; 29(9):2561-9. PubMed ID: 9299378
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the central anticholinergic activity of antidepressants. Comparison of two experimental methods].
Dufour P; Billa JP; Fabre J; Roquebert J
Ann Pharm Fr; 1989; 47(3):135-41. PubMed ID: 2634929
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical action of desipramine on the modulatory effect of bradykinin on noradrenaline release in a model of metabolic anoxia in rat isolated atria.
Foucart S; Grondin L; Couture R; Nadeau R
Can J Physiol Pharmacol; 1997 Jun; 75(6):646-51. PubMed ID: 9276143
[TBL] [Abstract][Full Text] [Related]
20. Biochemical pharmacology of pirenzepine. Similarities with tricyclic antidepressants in antimuscarinic effects only.
Bechtel WD; Mierau J; Pelzer H
Arzneimittelforschung; 1986 May; 36(5):793-6. PubMed ID: 3755340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
